Myelodysplastic syndromes: etiologies, evaluation, and therapy

Article Type
Changed
Fri, 01/04/2019 - 11:13
Display Headline
Myelodysplastic syndromes: etiologies, evaluation, and therapy

In this interview, Dr David Henry, MD, the Editor-in-Chief of JCSO, and David Steensma, MD, of the Dana-Farber Cancer Institute in Boston, talk about myelodysplasic syndromes, from diagnosis, evaluation, and etiologies, to therapy options and molecular sequencing.

 

Listen to the podcast below, or click on the PDF icon at the top of this introduction to read a transcript of the interview.​

 

Article PDF
Author and Disclosure Information

David Henry, MD, interviews David Steensma, MD

Publications
Topics
Sections
Author and Disclosure Information

David Henry, MD, interviews David Steensma, MD

Author and Disclosure Information

David Henry, MD, interviews David Steensma, MD

Article PDF
Article PDF

In this interview, Dr David Henry, MD, the Editor-in-Chief of JCSO, and David Steensma, MD, of the Dana-Farber Cancer Institute in Boston, talk about myelodysplasic syndromes, from diagnosis, evaluation, and etiologies, to therapy options and molecular sequencing.

 

Listen to the podcast below, or click on the PDF icon at the top of this introduction to read a transcript of the interview.​

 

In this interview, Dr David Henry, MD, the Editor-in-Chief of JCSO, and David Steensma, MD, of the Dana-Farber Cancer Institute in Boston, talk about myelodysplasic syndromes, from diagnosis, evaluation, and etiologies, to therapy options and molecular sequencing.

 

Listen to the podcast below, or click on the PDF icon at the top of this introduction to read a transcript of the interview.​

 

Publications
Publications
Topics
Article Type
Display Headline
Myelodysplastic syndromes: etiologies, evaluation, and therapy
Display Headline
Myelodysplastic syndromes: etiologies, evaluation, and therapy
Sections
Citation Override
JCSO 2016;14(11):479-483
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media